Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06286618 · ClinicalTrials.gov registry record · NA

Nutrition360: Moving to Integrated and Holistic Disease Prevention Among Underserved Mississippians

A NA study of Cardiovascular Diseases, sponsored by University of Southern Mississippi.

Completed
Registry status
NA
Development phase
24
Enrollment target
1
Study location

NCT06286618: Completed NA study of Cardiovascular Diseases, sponsored by University of Southern Mississippi.

NCT06286618 is a NA study of Cardiovascular Diseases that has completed, run by University of Southern Mississippi. The registered enrollment target is 24 participants, below the 26,974-participant average among 300 other Cardiovascular Diseases trials with a reported enrollment target (100% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06286618, a NA study of Cardiovascular Diseases, has completed, sponsored by University of Southern Mississippi.

COMPLETED
Registry status
NA
Development phase
24 participants
Enrollment target
1
Study location

Study Summary

The objective for the study is to implement a pilot study to establish essential components to address diet quality in healthcare settings and examine what value an integrated service model delivery has for the primary prevention of cardiometabolic diseases with an initial focus on dietary behaviors. This objective will be met by 1: Utilizing a multiphase optimization study design to select and optimize essential components to address diet behaviors and 2: Comparing an integrated and referral-based delivery model for healthcare-based strategies that address structural and psychosocial barriers to a healthy diet for racial/ethnic minority, marginalized and disadvantaged background young to middle aged adult populations in Mississippi.

Primary Outcome

An existing validated tool designed to assess research participant burden (Lingler et al., 2014) for cultural and contextual appropriateness; the tool includes 21 items assessed on a 5-point Likert agreement scale and the final adapted items will be summed for a total score. Higher scores mean a worse outcome.

Conditions Studied

Interventions

  • BEHAVIORAL Psychosocial Intervention
  • OTHER Structural Intervention
  • OTHER Traditional Psychosocial+Structural
  • OTHER Integrated Psychosocial+Structural

Study Locations (1)

Mississippi

  • The University of Southern Mississippi - Hattiesburg

Trial Details

FieldValue
Enrollment Target 24 participants
Start Date 2022-09-01
Est. Completion 2024-09-24
Phase NA

What the finished NCT06286618 record still lists

NCT06286618 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 24 participants, a relatively small participant target, below the 26,974-participant average among 300 other Cardiovascular Diseases trials with a reported enrollment target (100% lower).

The record links to 1 condition, with Cardiovascular Diseases appearing as the primary indexed condition, and to 4 interventions - of which Psychosocial Intervention is the first listed.

NCT06286618 reports a single indexed study location in Mississippi.

Frequently Asked Questions

What is clinical trial NCT06286618 about?

NCT06286618 is a clinical study titled "Nutrition360: Moving to Integrated and Holistic Disease Prevention Among Underserved Mississippians". The objective for the study is to implement a pilot study to establish essential components to address diet quality in healthcare settings and examine what value an integrated service model delivery has for the primary prevention of cardiometabolic diseases with an initial focus on dietary behaviors...

What is the current status of trial NCT06286618?

This trial is currently completed. It is a NA study. The enrollment target is 24 participants. The study started on 2022-09-01. Estimated completion is 2024-09-24.

What conditions does trial NCT06286618 study?

This clinical trial studies the following conditions: Cardiovascular Diseases.

What interventions are being tested in trial NCT06286618?

The interventions under investigation include: Psychosocial Intervention (BEHAVIORAL), Structural Intervention (OTHER), Traditional Psychosocial+Structural (OTHER), Integrated Psychosocial+Structural (OTHER).

Who is sponsoring clinical trial NCT06286618?

This trial is sponsored by University of Southern Mississippi, which has 7 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06286618 being conducted?

This trial has 1 study location across Mississippi. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Cardiovascular Diseases

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT06286618's enrollment target sits among peer trials

24 273rd of 300 higher than 25 of 300 other Cardiovascular Diseases trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Cardiovascular Diseases trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02331979 · 24 participants · NA

    Improving Bladder Function in SCI by Neuromodulation

  • NCT03096197 · 24 participants · NA

    Exoskeleton and Spinal Cord Stimulation for SCI

  • NCT03223922 · 24 participants · NA

    Neurocognitive Functioning With Genu-Sparing Whole Brain Radiation Therapy for Brain Metastases

  • NCT03326921 · 24 participants · Phase 1

    HA-1 T TCR T Cell Immunotherapy for the Treatment of Patients With Relapsed or Refractory Acute Leukemia After Donor Stem Cell Transplant

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT06286618, the US trial registry maintained by the National Library of Medicine. NCT06286618 (small enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.